These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10843201)

  • 21. Role of FDG PET in metastatic thyroid cancer.
    Wong CO; Dworkin HJ
    J Nucl Med; 1999 Jun; 40(6):993-4. PubMed ID: 10452316
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic factors affecting disease-specific survival in patients with recurrent and/or metastatic differentiated thyroid carcinoma detected by positron emission tomography/computed tomography.
    Akkas BE; Demirel BB; Vural GU
    Thyroid; 2014 Feb; 24(2):287-95. PubMed ID: 23750862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?].
    Arning G; Ehrenheim C; Schober O; Hundeshagen H
    Nuklearmedizin; 1987 Jun; 26(3):139-42. PubMed ID: 3628022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma.
    Lindegaard MW; Paus E; Høie J; Kullman G; Stenwig AE
    Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report].
    Ortega F; Maldonado A; Marañes P; Montz R; Pérez-Castejón MJ; Melgarejo M; Ruiz JA; Carreras JL
    Rev Esp Med Nucl; 1999; 18(1):50-4. PubMed ID: 10074219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative I131 whole-body scan and elevated thyroglobulin levels.
    Caobelli F; Pizzocaro C; Guerra UP
    Clin Nucl Med; 2013 Mar; 38(3):196. PubMed ID: 23357825
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative I131 whole- body scan and elevated thyroglobulin levels.
    Marcus CS
    Clin Nucl Med; 2013 Mar; 38(3):195. PubMed ID: 23354036
    [No Abstract]   [Full Text] [Related]  

  • 28. Silent parathyroid adenoma mistakenly interpreted on FDG-PET as thyroid cancer metastasis in a patient with elevated thyroglobulin and negative I-131 whole body scan and removed by radioguided minimally invasive surgery.
    Mendoza PL; Ongkeko EE; Santiago JF
    Clin Nucl Med; 2008 Jan; 33(1):23-5. PubMed ID: 18097251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I].
    Feine U; Lietzenmayer R; Hanke JP; Wöhrle H; Müller-Schauenburg W
    Nuklearmedizin; 1995 Aug; 34(4):127-34. PubMed ID: 7675641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
    Kim SJ; Lee TH; Kim IJ; Kim YK
    Eur J Radiol; 2009 Apr; 70(1):17-24. PubMed ID: 18207685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interlesional 'flip-flop' between
    Basu S; Kalshetty A; Fargose P
    Natl Med J India; 2017; 30(1):48. PubMed ID: 28731009
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of a diagnostic dose of 185 MBq 131I on postsurgical thyroid remnants.
    Bajén MT; Mañé S; Muñoz A; García JR
    J Nucl Med; 2000 Dec; 41(12):2038-42. PubMed ID: 11138690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the follow-up of Hürthle cell thyroid cancer.
    Plotkin M; Hautzel H; Krause BJ; Schmidt D; Larisch R; Mottaghy FM; Boemer AR; Herzog H; Vosberg H; Müller-Gärtner HW
    Thyroid; 2002 Feb; 12(2):155-61. PubMed ID: 11916285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal thymic uptake of 2-deoxy-2[F-18]fluoro-D-glucose.
    Alibazoglu H; Alibazoglu B; Hollinger EF; Ingram SA; Willoughby WA; LaMonica G; Ali A
    Clin Nucl Med; 1999 Aug; 24(8):597-600. PubMed ID: 10439182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography in non-medullary thyroid cancer.
    Ho Shon I; Depcynzski B; Lin M; Clark JR; Wong V; Lin P; Campbell P
    ANZ J Surg; 2011 Mar; 81(3):116-24. PubMed ID: 21342381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral axillary and infrahilar nodal metastases in follicular variant of papillary thyroid carcinoma (transformed into poorly differentiated subtype) in the setting of elevated thyroglobulin and negative radioiodine scintigraphy.
    Basu S
    J Cancer Res Ther; 2016; 12(1):423-4. PubMed ID: 27072275
    [No Abstract]   [Full Text] [Related]  

  • 37. [Rosiglitazone in two patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer: preliminary results].
    Martín T; Torres A; Cambil T; Castro J
    Med Clin (Barc); 2008 Oct; 131(11):435. PubMed ID: 18928727
    [No Abstract]   [Full Text] [Related]  

  • 38. Usefulness of the diagnostic total body scan in differentiated thyroid cancer.
    Doi SA
    J Clin Endocrinol Metab; 2001 Feb; 86(2):949-50. PubMed ID: 11158080
    [No Abstract]   [Full Text] [Related]  

  • 39. Value of the estimation of thyroglobulin levels in the surveillance of treated differentiated thyroid carcinoma.
    Sulman C; Gosselin P; Carpentier P; Lemaire B
    J Clin Chem Clin Biochem; 1984 Mar; 22(3):215-8. PubMed ID: 6427386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining a rational step-care algorithm for managing thyroid carcinoma patients with elevated thyroglobulin and negative on radioiodine scintigraphy (TENIS): considerations and challenges towards developing an appropriate roadmap.
    Basu S; Dandekar M; Joshi A; D'Cruz A
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1167-71. PubMed ID: 25989850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.